Select Your Country/Region

United States English
中国(大陆) 简体中文
España Español
CIS Русский
日本 日本語
Deutschland Deutsch
Italia Italian
Portugal Português
Philippines Philippines
Europe English
Global (Other country or region) English

It seems you're in Hong Kong.Redirect to Global Site to see the content specific to your location and shop online.

All Where to Buy About Chuwi Contact Us Blogs Company News Video Center

Review Raises Concerns About Women's Libido Drug Flibanserin [5adcc8]

2025-02-21 by CHUWI

Post Time: 2025-02-21

Error: No content files found.There are new concerns about the safety of the only female libido drug approved by the FDA. Flibanserin, sold under the brand name Addyi, was approved last summer. Supporters called it a victory for women suffering from this article lower sexual desire, but a review in a medical journal questions the quality of my latest blog post the drug. Dr. Tara Narula joins “CBS go source This Morning” to discuss the findings.
Review raises concerns about women's libido drug flibanserin
Review Raises Concerns About Women's Libido Drug Flibanserin [5adcc8]